Steven M. Foster - 26 Apr 2022 Form 3 Insider Report for Tenon Medical, Inc. (TNON)

Role: CEO and President, Director
Signature: /s/ Steven M. Foster
Issuer symbol: TNON
Transactions as of: 26 Apr 2022
Net transactions value: $0
Form type: 3
Filing time: 26 Apr 2022, 21:38:45 UTC
Next filing: 16 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TNON	Common Stock						15,372	26 Apr 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TNON	Stock Options							26 Apr 2022	Common Stock	112,500	$5.20	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 15,372 shares of common stock issuable upon the automatic conversion of a convertible note on the closing of the initial public offering of Tenon Medical, Inc. to occur on April 29, 2022.
F2	Steven Foster was granted an option to purchase 225,000 shares (or 112,500 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $2.60 (or $5.20 post-split) per share with a grant date of May 1, 2021, subject to monthly equal vesting over a three-year period commencing May 1, 2021.
F3	34,375 shares of common stock underlying stock options have vested as of April 26, 2022.